Fujifilm Acquiring Irvine Scientific, IS Japan for $800M, with Cell Culture Media Growth in...

Both companies to be acquired serve biopharmas and academic institutions by offering culture media for biopharmaceutical production, in vitro fertilization, and cell therapy

Biovest and Ordway Research Institute to Evaluate Firm’s Technology for Producing Virus-Fighting Products

Studies will establish prototype for large-scale production of viruses using Biovest's hollow fiber bioreactor systems.

Domain Collabs with Canadian Universities on Biosensor Technology

Domain Therapeutics inked a licensing and partnership agreement on G-protein coupled receptors (GPCR) biosensor technology with Université de Montréal (UdeM) and its commercialization unit, with the Institute for Research in Immunology and Cancer–Commercialization of...

Thermo Opens New Facility in China

Thermo Fisher Scientific is opening a new facility in Suzhou, China, for the manufacturing of life sciences consumables and equipment.

EMD Millipore Inks Biomanufacturing Deal with Samsung BioLogics

EMD Millipore and Samsung BioLogics signed a Memorandum of Understanding (MOU) for a strategic alliance to encompass a long-term supply agreement.
Synthetic biologists have established a DNA-encoded and readily engineered bacterial platform for borylation that outpaces conventional chemical methods. The feat marks the first time that bacteria have made compounds with boron–carbon bonds. In this artist's interpretation

Synthetic Biology Forges Boron–Carbon Bonds in Living Cells

Synthetic biologists establish a DNA-encoded and readily engineered bacterial platform for borylation that outpaces conventional chemical methods

Gore PharmBIO Opens Production Plant to Double Capacity

Enhanced cleanroom is key feature. Gore PharmBIO Products opened a new manufacturing facility, which doubles its capacity. Located in Elkton, MD, the site will house a cleanroom that is designed to be more efficient and...

Selexis Provides Zyngenia with Cell-Line Services for Antibody Production

Firm claims Genetic Elements platform can reduce development time to five weeks.

EMD Millipore, Centre for Commercialization of Regen Med to Optimize Large-Scale Stem Cell Cultivation

Monitoring and control methodology will be developed for EMD’s Mobius CellReady bioreactor.

ATMI Supplies Bioreactor for Orgenesis, Takes $1.3M Stake

Integrity® Xpansion™ will be integrated into Orgenesis' therapy, which converts liver cells to insulin-producing cells.

Recently Featured

Scroll Up